Lily Prozac
Executive Summary
Fluoxetine approved Oct. 7 for the treatment of geriatric depression. Approval was based on data from two placebo-controlled studies in approximately 700 depressed patients over age 60
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
PS034969
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.
All fields are required.
PS034969
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.